The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

Similar documents
8.0 Take Home Naloxone

Analysis of Greater Glasgow & Clyde IEP Data John Campbell

Drug Consumption Rooms Worldwide

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

Saskatchewan HIV Strategy: Social Network Approach

HIV in Glasgow. Responding to an Outbreak. A special bulletin to commemorate World AIDS Day 2018

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

Drug Consumption Rooms: Legal barriers or just an excuse? Kirstie Douse Head of Legal Services Solicitor Advocate

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Guidelines For Services Providing Injecting Equipment

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

Feasibility study on drug consumption rooms in Belgium (DRUGROOM) Summary

NHS FORTH VALLEY LOCAL ENHANCED SERVICE (2010) General Practitioner Prescribing Service (GPPS) Opiate Assisted Treatment Service Specification

4.0 Current Service Configuration

NEW PSYCHOACTIVE SUBSTANCES (LEGAL HIGHS) INFORMATION SUPPORTING RAG ANALYSIS

Take Home Naloxone Report on supply and use to reverse an overdose

Victorian AIDS Council Gay Men s Health Centre

Monthly measles and rubella monitoring report

Evidence-based interventions for managing illicit drug dependence

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Substance Misuse and Harm Reduction. Training Programme. Autumn 2018

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

Patient navigators for hepatitis C patients found useful in New York City

Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis

Jill Davidson CEO SHine SA. On Line Chlamydia Initiative

Borders Alcohol & Drugs Partnership Workforce Development and Training Directory

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

6.1.2 Other multi-agency groups which feed into the ADP and support the on-going work includes:

Needle and Syringe Programs - 17 October 2013

Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better.

>Hepatitis NSW will continue to

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

THE PORTUGUESE COMMUNITY SCREENING NETWORK

The Challenge of offering a spectrum of alcohol services to homeless people. Pam Campbell

The Silent Disease Inquiry into Hepatitis C in Australia

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

Signs of success latest national NESI data?

Public Health Association of British Columbia

Place of addiction-informed comprehensive treatment in HIV care

The National Hepatitis C Plan - Scotland

Public drug policies Catalonia

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

Background: Kirketon Road Centre

An Overview of a Provincial Appropriateness of Care Initiative: A Provincial Collaborative Supporting Appropriate, Affordable, and Accessible Care

What difference does it make? Assessing the impact of take-home naloxone scale up internationally

Drug Use, Harm Reduction, and HIP

HARM REDUCTION IN CANADA LESSONS LEARNED AND REFLECTIONS. Marilou Gagnon, RN, PhD Associate Professor School of Nursing University of Victoria

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Building a New Approach to Health Care Services for Hard to Reach Clients

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

Prison needle exchange: Review of the evidence

Statistics on Drug Misuse: England, 2007

Promoting hepatitis B vaccination

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

As a result of this training, participants will be able to:

Targeted Outreach & Other Strategies for Increasing HCV Testing

HCV ACTION CARDIFF HEPATITIS C GOOD PRACTICE ROADSHOW, 8TH DECEMBER 2017 SUMMARY REPORT

Summary of Expected Insights from Oral PrEP Projects in Kenya. LVCT Health in partnership with FSG and AVAC

HIV WHAT WORKERS NEED TO KNOW

Hepatitis C treatment program improves access to housing, income and healthcare

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Harm Reduction in Nigeria

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

National Xpert MTB/RIF Programme

The Impact of the Opioid Crisis. Deborah A. McMahan, MD Health Commissioner Allen County Department of Health

Addiction Therapy-2014

The Opioid Addiction Emergency In Virginia June 8, 2017

Substance use and misuse

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Edinburgh Access Practice Hepatitis C Clinic Jessie Anderson, Kim McBeth, John Budd and Rebecca Martin

Item No: 8. Meeting Date: Wednesday 12 th December Glasgow City Integration Joint Board

Addiction and Substance misuse pathways

Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013

Here are some of the steps (greatly simplified) and gaps that can occur in the HIV Treatment Cascade:

Questions & Answers. What are the risks associated with consumption drug use?

PROJECT BRIDGE: Differentiation of HIV Services for PWID in Harm Reduction Programs in Kazakhstan. Nabila El-Bassel, PhD Columbia University

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

The Opioid Overdose Crisis: Role of the TB Physician

INTRAVENOUS INJECTING DRUG USE.

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives

The Pillars Approach: A Case Study

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

HCV: how do we reach elimination from a clinicians perspective. A/Professor Gail Matthews

Urban Village Medical Practice Service Review An integrated model for high quality healthcare for homeless people in Manchester

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018

Treatment of Hepatitis C in People Who Inject Drugs (PWIDs) Andrew Seaman, MD OHA P&T Meeting January, 2017

Part 1: Introduction & Overview

Transcription:

The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre

No conflicts to declare

Potted History 1981 Modern wave of drug misuse Glasgow soared from 34-174 (heroin) 1983 outbreak of HIV among IV drug users in Edinburgh: over 60%infected in 6 months 1987 First needle exchange set up in Edinburgh - 1989 Glasgow 1988 Methadone prescribing introduced in Edinburgh by GP s 1992 Glasgow

Needle exchange 1989 Pharmacy needle exchange rejected by Scottish Health Minister Hospital gate 2 half days inaccessible Easterhouse drug project evening 5 months later moved to Easterhouse Health Centre 100 clients daily Replicated in other parts of the city 5 needles on first visit 15 subsequent visits

Opened 1994 Glasgow Drug Crisis Centre City Centre accessible to all comers One stop facility, homelessness, physical and mental health, legal and child care issues 24 hour needle exchange In1997/1998 over 3,000 individuals used the service

New HIV diagnoses among people who inject drugs GGC

PWID HIV outbreak 120 new infections since November 2014 amongst PWIDs in Glasgow city 2015=48 2016=30 2017=37 2018=5 (to May) Extensive use of IEP services Epidemiologically and virologically linked Clade C virus

PWIDs - Socially excluded Homelessness Addictions Criminalisation Drugs/sex work Financial Barriers to accessing healthcare traditional model of care High rates of violence (*women) drug/debt related

What happened? We Took our eye off the ball

Brownlee Centre

Awareness / Education Spreading the word by all services in contact with the population group is essential 14

Broader context...anthrax, botulism, Staph aureus bacteraemia, drug deaths...

Daily priorities Accommodation Opiate replacement therapy Finance Drugs/alcohol Avoiding others Health needs

Healthcare attitudes Drug/alcohol intoxication Difficult patients Present in crisis Adherence to medication Drug-drug interactions Non attendance for investigations Multiple co-morbidities Complex co-morbidities 16 Deaths 12% of cohort Stigma

What to do? Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations Philip et al The Journal of Infectious Diseases, Volume 215, Issue 10, 15 May

Accessing healthcare In and out of prison Sleeping rough on streets Drug & alcohol use affects priorities A&E IP 2 2 7 12 4 1 9 5 7 1 2 2 1 1 1 Mar Apr May June July Aug Sept Oct Nov Dec Jan Feb Mar Apr May June July Aug Sep Oct Prison clinic HIV service DNA DNA DNA DNA DNA Attended

Change model of service?

Adapting to need Adapt services to meet the needs of the vulnerable Alternative service model in reach model homeless health services addictions services, mental health, homeless health combined GUM/ID expertise to provide input to sexual, reproductive and medical issues Links with other services, voluntary sector, ED HIV medication dispensed in community outreach model nurse led a holistic approach to providing HIV/BBV care

A day in the life of

Does it work? HIV medication 102/104 (98%) have ever received ART 95/104 (91%) are currently receiving ART 45/104 (42%) currently receiving via community pharmacy Adherence varies from 10% to 99% 72/104 (69%) have an HIV viral load <40 copies/ml Nurse-Led BBV clinic in homeless health service 43/104 (41%) have attended (NMP)

What still needs to be done? 100% engagement in care Needs adequate dedicated nursing staff Multiagency integration Prisons Addictions Mental health Third sector Treatment of hepatitis C At least 40 requiring treatment Ongoing care and support...lifetime risks Other possibilities Injectable treatment (+/- PrEP) PrEP

HIV testing

DRUG CONSUMPTION Place where problem drug users are allowed to bring their illegally-obtained drugs and take them in a supervised, hygienic environment. Sterile injecting equipment. Closely observed, in order to give medical assistance should they overdose. c. 90 DCRs operating in 10 countries: Switzerland, Germany, the Netherlands, Spain, Norway, Luxembourg, Australia, Canada, Denmark and Greece. Advanced plans in France

DCR There is no legal framework for the provision of drug consumption rooms in the UK and we have no plans to introduce them, the Home Office said. Operating an injection facility would be likely to mean committing a range of offences including encouraging or assisting the possession and supply of controlled drugs, it added

Vancouver

Zurich

Summary Hard to reach groups Much more than managing HIV Risk vs benefit clinical decisions Multidisciplinary and multiagency approach Building relationships/trust Outreach work invaluable Develop and adapt service models to suit cohort Communication is key HIV prevention is complex